Register
Why register?
- Download your favorite videos
- Build & share playlists with friends
- Get updates on new videos & podcasts
Registation Options:

Login


You can also
Forgot your password?
top-left
top-right
Gordon Ringold
Surromed

Dr. Ringold was most recently CEO of the Glaxo-Wellcome Group's Affymax Research Institute, where he managed the development of novel technologies to accelerate the pace of drug discovery. He is a co-founder and director of Maxygen Corporation, a Managing Partner of Technogen Associates, L.P., a private investment firm, and has over fifteen years of experience managing the discovery and development of pharmaceuticals and novel, enabling life science technologies. Prior to Affymax, Dr. Ringold served as Director and Vice President of the Institute for Cancer and Developmental Biology at Syntex, now a division of Hoffman La-Roche. Dr. Ringold received his B.A. in Biology from UC Santa Cruz, and his Ph.D. in Microbiology from UC San Francisco. He was on the faculty of the Department of Pharmacology at the Stanford University School of Medicine, and is currently a consulting professor there.

Related Links: www.surromed.com   

Last Updated: Wed, Apr 19, 2006

bottom-left
bottom-left

Displaying 14 results for Gordon Ringold  Page: 1

Category Title Author/Speaker Organization Length Date
Video Being an Entrepreneur in Industry vs. Education: Team vs. Individual Gordon Ringold Surromed 01:37 02/2003
Video Biggest Pharmaceutical Products in Industry Today Gordon Ringold Surromed 02:00 02/2003
Video Biotech: Collaboration vs. Competition in Developing Affymax Gordon Ringold Surromed 02:58 02/2003
Video Change the Business Plan in Response to a Changing Environment Gordon Ringold Surromed 04:03 02/2003
Video Funding Challenges in Today's Market Gordon Ringold Surromed 01:21 02/2003
Video History: From Bayer to Affymax Gordon Ringold Surromed 03:20 02/2003
Video History of Maxygen Gordon Ringold Surromed 01:21 02/2003
Video History of Surromed Gordon Ringold Surromed 16:12 02/2003
Video How to Operate in a Downturn Economy Gordon Ringold Surromed 01:15 02/2003
Video Importance of Passion Gordon Ringold Surromed 01:15 02/2003
Video Pharmaceutical Companies: Challenges in Developing New Therapeutic Products Gordon Ringold Surromed 01:56 02/2003
Video Types of Company in Biotech Gordon Ringold Surromed 02:46 02/2003
Video What is an Entrepreneur? Gordon Ringold Surromed 01:59 02/2003
Video When and How are Patents Important? Gordon Ringold Surromed 01:41 02/2003